0
     

Report Added
Report already added
Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique Type, End User and Region (North America, APAC, MEA, Europe, Latin America) - Global Forecast to 2027

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique Type, End User and Region (North America, APAC, MEA, Europe, Latin America) - Global Forecast to 2027

The global lateral flow assay components market is projected to reach USD 420 million by 2027 from USD 339 million in 2022, at a CAGR of 4.3% during the forecast period. The high prevalence of infectious diseases worldwide, rapid growth in the geriatric population, the growing demand for point-of-care testing, the increased demand for lateral flow assay components due to COVID-19, and the rising use of home-based lateral flow assay devices are the major factors driving the growth of the lateral flow assay components market.

“Membranes segment accounted for the largest share in the lateral flow assay components market.”

Based on type, the lateral flow assay components market is segmented into membranes, pads, and others. In 2021, membranes accounted for the largest share of 58.8% of the global lateral flow assay components market. This segment is projected to reach USD 245.6 million by 2027 from 198.8 million in 2022, at a CAGR of 4.3% during the forecast period. The large share of this segment can be attributed to the increasing applications of lateral flow assay kits & reagents for POC testing, the growing burden of chronic diseases, the increasing use of lateral flow assay kits in home care settings, and their convenience and ease of use.

The lateral flow assay membranes market is further bifurcated into nitrocellulose and other membranes. In 2021, the nitrocellulose membranes segment accounted for the largest share of 98.3% of the global lateral flow assay membranes market. Nitrocellulose membranes are mainly used to make lateral flow immunoassays.

The lateral flow assay pads market is further bifurcated into sample pads, conjugate pads, and absorbent pads. In 2021, the sample pads segment accounted for 56.4% of the lateral flow assay pads market.

“Clinical Testing segment is expected to witness the fastest growth in the forecast period.”

Based on applications, the lateral flow assay components market is segmented into clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing. The clinical testing segment accounted for the largest share of 94.5% of the lateral flow assay components market in 2021. The large share of this segment can be attributed to the rising prevalence of chronic diseases, the growing pressure to reduce healthcare costs, and the increasing demand for patient-centric care.

“Sandwich assays technique accounted for the largest share of lateral flow assay components market in 2021”

Based on techniques, the lateral flow assay components market is segmented into competitive assays, sandwich assays, and multiplex detection assays. Sandwich assays dominated the lateral flow assay components market in 2021, with a share of 80.9%. The large share of this segment can be attributed to its better assay sensitivity and specificity as well as its extensive applications in the measurement of critical analytes (such as cardiac and hepatitis markers).

“The medical device manufacturing company accounted for the largest share of lateral flow assays components market in 2021”

Based on end users, the lateral flow assay components market is segmented into medical device manufacturing companies and medical device contract manufacturing companies. Medical device manufacturing companies accounted for the largest market share of 69.3% of the lateral flow assay components market in 2021. The COVID-19 pandemic has also increased the demand for point-of-care testing in professional healthcare settings, which increases the demand for lateral flow assay components among medical device manufacturing companies.

“North America accounted for the largest share of the lateral flow assay components market in 2021”

In 2021, North America accounted for the largest share of 49.4% of the lateral flow assay components market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. However, the APAC region is expected to grow at the highest CAGR of 7.1% during the forecast period. The rapidly developing raw material industry in China and India, the growing number of local manufacturers for lateral flow assay components, increasing investments in the region by key market players, the availability of low-cost labor for manufacturing, and the presence of a favorable regulatory environment are the key factors driving market growth in the APAC. The current COVID-19 scenario and its high impact in the Asia Pacific region (especially India) have also resulted in a high growth rate in the lateral flow assay components market in this region.

A breakdown of the primary participants (supply-side) for the lateral flow assay components market referred to for this report is provided below:
•By Company Type: Tier 1–35%, Tier 2–20%, and Tier 3–45%
•By Designation: C-level–45%, Director Level–25%, and Others–30%
•By Region: North America–36%, Europe–26%, Asia Pacific–21%, Latin America- 10%, and Middle East and Africa– 7%
The prominent players in this market include Danaher Corporation (Cytiva Life Science and Pall Corporation) (US), Merck KGaA (Germany), Sartorius Stedim Biotech (Germany), Ahlstrom-Munksjö (Finland), Advanced Microdevice Pvt. Ltd. (India), Hangzhou Cobetter Filtration System Co., Ltd. (China), Axiva-Axiflow Group (India), Nupore Filtration (India), DCN Diagnostics (US), and Ballya Bio (China).

Research Coverage:
The market study covers the lateral flow assay components market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by type, application, by technique, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the lateral flow assay components market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.
Table of Contents

1INTRODUCTION33
1.1OBJECTIVES OF THE STUDY33
1.2MARKET DEFINITION33
1.2.1CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET33
1.3MARKET SCOPE34
1.3.1MARKETS COVERED34
FIGURE 1LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION34
1.3.2YEARS CONSIDERED FOR THE STUDY35
1.4CURRENCY35
TABLE 1EXCHANGE RATES UTILIZED FOR CONVERSION TO USD35
1.5STAKEHOLDERS35
2RESEARCH METHODOLOGY36
2.1RESEARCH APPROACH36
FIGURE 2RESEARCH DESIGN36
2.1.1SECONDARY DATA36
2.1.1.1Key data from secondary sources37
2.1.2PRIMARY DATA38
2.1.2.1Primary sources38
2.1.2.2Key data from primary sources39
2.1.2.3Breakdown of primaries39
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION39
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION40
2.2MARKET SIZE ESTIMATION40
FIGURE 5MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021)41
FIGURE 6SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021)42
2.3MARKET BREAKDOWN & DATA TRIANGULATION44
FIGURE 7DATA TRIANGULATION METHODOLOGY45
2.4KEY INDUSTRY INSIGHTS46
2.5LIMITATIONS46
2.5.1METHODOLOGY-RELATED LIMITATIONS46
2.6RISK ASSESSMENT47
2.7ASSUMPTIONS FOR THE STUDY47

3EXECUTIVE SUMMARY48
FIGURE 8LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION)48
FIGURE 9LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION)49
FIGURE 10LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION)50
FIGURE 11LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION)51
FIGURE 12GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET52
4PREMIUM INSIGHTS53
4.1LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW53
FIGURE 13RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET53
4.2REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET54
FIGURE 14APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD54
4.3ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY55
FIGURE 15MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 202155
4.4LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES56
4.5LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES56
5MARKET OVERVIEW57
5.1INTRODUCTION57
5.2MARKET DYNAMICS: IMPACT ANALYSIS57
5.2.1DRIVERS58
5.2.1.1Growing demand for lateral flow assay kits due
to the COVID-19 pandemic58
5.2.1.2Growing usage of home-based lateral flow assay devices58
5.2.1.3Growing demand for point-of-care testing58
5.2.1.4Increasing public-private investments to develop lateral flow assays59
5.2.2RESTRAINTS59
5.2.2.1Availability of alternative diagnostic technologies59
5.2.3OPPORTUNITIES59
5.2.3.1Evolving applications of lateral flow assays59
5.2.4CHALLENGES60
5.2.4.1Requirement of specialized storage and shipping facilities for membranes60
5.3ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET60
5.4TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET60
FIGURE 16YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET61
5.5AVERAGE SELLING PRICE TREND61
TABLE 2AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD)61
5.6ECOSYSTEM MARKET MAP62
FIGURE 17ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021)62
5.7PATENT ANALYSIS63
5.7.1PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS63
FIGURE 18GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–202164
5.7.2JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET64
FIGURE 19JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–202164
5.8VALUE CHAIN ANALYSIS65
5.9REGULATORY LANDSCAPE66
TABLE 3REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION66
5.9.1NORTH AMERICA66
5.9.2EUROPE67
5.9.3ASIA PACIFIC67
5.9.3.1India67
5.9.3.2China67
5.9.3.3Japan68
5.10TECHNOLOGY ANALYSIS69
5.10.1KEY TECHNOLOGY: LATERAL FLOW ASSAYS69
5.11KEY CONFERENCES & EVENTS DURING 2021–202369
TABLE 4LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS69
5.12KEY STAKEHOLDERS & BUYING CRITERIA70
5.12.1KEY STAKEHOLDERS IN THE BUYING PROCESS70
FIGURE 20INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS70
TABLE 5INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS70
5.12.2BUYING CRITERIA71
FIGURE 21KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS71
TABLE 6KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS71
5.13PORTER’S FIVE FORCES ANALYSIS72
TABLE 7LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS72
5.13.1THREAT FROM NEW ENTRANTS72
5.13.2THREAT FROM SUBSTITUTES72
5.13.3BARGAINING POWER OF BUYERS73
5.13.4BARGAINING POWER OF SUPPLIERS73
5.13.5INTENSITY OF COMPETITIVE RIVALRY73
6LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE74
6.1INTRODUCTION75
TABLE 8LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)75
6.2MEMBRANES75
TABLE 9LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION)76
TABLE 10LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION)76
6.2.1NITROCELLULOSE MEMBRANES77
6.2.1.1Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth77
TABLE 11LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION)77
TABLE 12LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS)78
TABLE 13LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS)78
6.2.2OTHER MEMBRANES78
TABLE 14LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION)79
6.3PADS80
TABLE 15EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS80
TABLE 16LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION)80
TABLE 17LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION)81
6.3.1SAMPLE PADS81
6.3.1.1Ability to promote even and controlled distribution of samples to drive market growth81
TABLE 18LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION)82
6.3.2CONJUGATE PADS82
6.3.2.1Conjugate pads play an important role in controlling the performance of lateral flow immunoassays82
TABLE 19LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION)83
6.3.3ABSORBENT PADS84
6.3.3.1Absorbent pads prevent backflow—a key factor driving market growth84
TABLE 20LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION)84
6.4OTHER COMPONENTS84
TABLE 21OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)85
7LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION86
7.1INTRODUCTION87
TABLE 22LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)87
7.2CLINICAL TESTING87
TABLE 23LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)88
TABLE 24LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION)88
7.2.1INFECTIOUS DISEASE TESTING89
7.2.1.1Rising demand for infectious disease testing in emerging markets to drive market growth89
TABLE 25LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION)89
7.2.2PREGNANCY & FERTILITY TESTING90
7.2.2.1Growing infertility levels due to changing lifestyles—a key factor driving market growth90
TABLE 26LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION)90
7.2.3CARDIAC MARKER TESTING91
7.2.3.1Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment91
TABLE 27LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION)92
7.2.4CHOLESTEROL TESTING/LIPID PROFILING92
7.2.4.1Growing prevalence of obesity and CVD—
a key factor driving market growth92
TABLE 28LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION)93
7.2.5DRUGS-OF-ABUSE TESTING93
7.2.5.1Technological advancements and a growing focus on workplace
drug testing are driving market growth93
TABLE 29LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION)94
7.2.6OTHER CLINICAL TESTING APPLICATIONS94
TABLE 30LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)95
7.3VETERINARY DIAGNOSTICS95
7.3.1INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH95
TABLE 31LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)96
7.4FOOD SAFETY & ENVIRONMENTAL TESTING96
7.4.1HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING96
TABLE 32LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)97
7.5DRUG DEVELOPMENT & QUALITY TESTING97
7.5.1INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS97
TABLE 33LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)98
8LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE99
8.1INTRODUCTION100
TABLE 34LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION)100
8.2SANDWICH ASSAYS100
8.2.1SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT100
TABLE 35LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION)101
8.3COMPETITIVE ASSAYS101
8.3.1REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH101
TABLE 36LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION)102
8.4MULTIPLEX DETECTION ASSAYS102
8.4.1INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH102
TABLE 37LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION)103
9LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER104
9.1INTRODUCTION105
TABLE 38LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION)105
9.2MEDICAL DEVICE MANUFACTURING COMPANIES105
9.2.1INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES105
TABLE 39LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)106
9.3MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES106
9.3.1GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH106
TABLE 40LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION)107

10LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION108
10.1INTRODUCTION109
FIGURE 22CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD109
TABLE 41LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION)110
10.2NORTH AMERICA110
TABLE 42NORTH AMERICA: MACROECONOMIC INDICATORS110
FIGURE 23NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT111
TABLE 43NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)112
TABLE 44NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)112
TABLE 45NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION)112
TABLE 46NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION)113
TABLE 47NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)113
TABLE 48NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)114
TABLE 49NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION)114
TABLE 50NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION)115
10.2.1US115
10.2.1.1Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US115
TABLE 51US: MACROECONOMIC INDICATORS116
TABLE 52US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)116
TABLE 53US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)116
TABLE 54US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION)117
TABLE 55US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)117
TABLE 56US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)118
TABLE 57US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION)118
TABLE 58US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION)119
10.2.2CANADA119
10.2.2.1Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US119
TABLE 59CANADA: MACROECONOMIC INDICATORS119
TABLE 60CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)120
TABLE 61CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)120
TABLE 62CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)120
TABLE 63CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)121
TABLE 64CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)121
TABLE 65CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)122
TABLE 66CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)122
10.3EUROPE122
TABLE 67EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)123
TABLE 68EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)123
TABLE 69EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)123
TABLE 70EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)124
TABLE 71EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)124
TABLE 72EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)125
TABLE 73EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)125
TABLE 74EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)126
10.3.1GERMANY126
10.3.1.1Growing demand for POC testing to drive the lateral flow assay components market in Germany126
TABLE 75GERMANY: MACROECONOMIC INDICATORS126
TABLE 76GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)127
TABLE 77GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)127
TABLE 78GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)127
TABLE 79GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)128
TABLE 80GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)128
TABLE 81GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)129
TABLE 82GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)129
10.3.2FRANCE129
10.3.2.1High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France129
TABLE 83FRANCE: MACROECONOMIC INDICATORS130
TABLE 84FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)130
TABLE 85FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)130
TABLE 86FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)131
TABLE 87FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)131
TABLE 88FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)132
TABLE 89FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)132
TABLE 90FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)133
10.3.3UK133
10.3.3.1Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK133
TABLE 91UK: MACROECONOMIC INDICATORS134
TABLE 92UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)134
TABLE 93UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)134
TABLE 94UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION)135
TABLE 95UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION)135
TABLE 96UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)136
TABLE 97UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION)136
TABLE 98UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION)137
10.3.4ITALY137
10.3.4.1Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country137
TABLE 99ITALY: MACROECONOMIC INDICATORS137
TABLE 100ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)138
TABLE 101ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)138
TABLE 102ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION)138
TABLE 103ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)139
TABLE 104ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)139
TABLE 105ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION)140
TABLE 106ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION)140
10.3.5SPAIN140
10.3.5.1Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth140
TABLE 107SPAIN: MACROECONOMIC INDICATORS141
TABLE 108SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)141
TABLE 109SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)142
TABLE 110SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION)142
TABLE 111SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)142
TABLE 112SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)143
TABLE 113SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)143
TABLE 114SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION)144
10.3.6REST OF EUROPE144
TABLE 115ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)144
TABLE 116ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)145
TABLE 117ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION)145
TABLE 118ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)145
TABLE 119ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)146
TABLE 120ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION)146
TABLE 121ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION)147
10.4ASIA PACIFIC147
FIGURE 24ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT148
TABLE 122APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)149
TABLE 123APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)149
TABLE 124APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)149
TABLE 125APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION)150
TABLE 126APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)150
TABLE 127APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)151
TABLE 128APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION)151
TABLE 129APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION)152
10.4.1CHINA152
10.4.1.1Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country152
TABLE 130CHINA: MACROECONOMIC INDICATORS153
TABLE 131CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)153
TABLE 132CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)153
TABLE 133CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION)154
TABLE 134CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)154
TABLE 135CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)155
TABLE 136CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)155
TABLE 137CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION)156
10.4.2JAPAN156
10.4.2.1Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan156
TABLE 138JAPAN: MACROECONOMIC INDICATORS157
TABLE 139JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)157
TABLE 140JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)157
TABLE 141JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION)158
TABLE 142JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)158
TABLE 143JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)159
TABLE 144JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)159
TABLE 145JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION)160
10.4.3INDIA160
10.4.3.1Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market160
TABLE 146INDIA: MACROECONOMIC INDICATORS160
TABLE 147INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)161
TABLE 148INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)161
TABLE 149INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION)161
TABLE 150INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)162
TABLE 151INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)162
TABLE 152INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION)163
TABLE 153INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION)163
10.4.4AUSTRALIA164
10.4.4.1Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia164
TABLE 154AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)164
TABLE 155AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)164
TABLE 156AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)165
TABLE 157AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)165
TABLE 158AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)166
TABLE 159AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)166
TABLE 160AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)167
10.4.5REST OF ASIA PACIFIC167
TABLE 161ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION)167
TABLE 162ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)168
TABLE 163ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)168
TABLE 164ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)168
TABLE 165ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)169
TABLE 166ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)169
TABLE 167ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)170

10.5LATIN AMERICA170
10.5.1HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET170
TABLE 168LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)171
TABLE 169LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION)171
TABLE 170LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION)171
TABLE 171LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)172
TABLE 172LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)172
TABLE 173LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION)173
TABLE 174LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION)173
10.6MIDDLE EAST & AFRICA173
10.6.1SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS173
TABLE 175MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS174
TABLE 176MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION)174
TABLE 177MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION)175
TABLE 178MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION)175
TABLE 179MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION)175
TABLE 180MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)176
TABLE 181MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION)176
TABLE 182MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION)177
11COMPETITIVE LANDSCAPE178
11.1OVERVIEW178
11.2KEY PLAYER STRATEGIES/RIGHT TO WIN178
FIGURE 25OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET179
11.3REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET179
FIGURE 26REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET180
11.4MARKET SHARE ANALYSIS180
FIGURE 27LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)181
TABLE 183LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION182
11.5R&D ASSESSMENT OF KEY PLAYERS183
FIGURE 28R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020183
11.6GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS183
FIGURE 29GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021)184
11.7COMPANY EVALUATION QUADRANT184
11.7.1STARS184
11.7.2PERVASIVE PLAYERS184
11.7.3EMERGING LEADERS185
11.7.4PARTICIPANTS185
FIGURE 30LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021185
11.8COMPETITIVE BENCHMARKING186
11.8.1OVERALL COMPANY FOOTPRINT186
TABLE 184OVERALL COMPANY FOOTPRINT (17 COMPANIES)186
TABLE 185COMPANY FOOTPRINT: BY TYPE (17 COMPANIES)187
TABLE 186COMPANY FOOTPRINT: BY REGION (17 COMPANIES)188
11.9COMPETITIVE SCENARIO188
11.9.1DEALS189
TABLE 187DEALS, JANUARY 2019–FEBRUARY 2022189
11.9.2OTHER DEVELOPMENTS189
TABLE 188OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022189
12COMPANY PROFILES190
12.1KEY PLAYERS190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE)190
TABLE 189DANAHER CORPORATION: BUSINESS OVERVIEW190
FIGURE 31DANAHER CORPORATION: COMPANY SNAPSHOT (2020)191
12.1.2SARTORIUS STEDIM BIOTECH195
TABLE 190SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW195
12.1.3MERCK KGAA199
TABLE 191MERCK KGAA: BUSINESS OVERVIEW199
FIGURE 33MERCK KGAA: COMPANY SNAPSHOT (2020)200
12.1.4AHLSTROM-MUNKSJÖ204
TABLE 192AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW204
FIGURE 34AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020)205
12.1.5ADVANCED MICRODEVICES PVT. LTD.208
TABLE 193ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW208
12.1.6DCN DIAGNOSTICS210
TABLE 194DCN DIAGNOSTICS: BUSINESS OVERVIEW210
12.2OTHER PLAYERS211
12.2.1FORTIS LIFE SCIENCES211
TABLE 195FORTIS LIFE SCIENCES: BUSINESS OVERVIEW211
12.2.2HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD212
TABLE 196HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW212
12.2.3AXIVA SICHEM BIOTECH214
TABLE 197AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW214
12.2.4NUPORE FILTRATION SYSTEM216
TABLE 198NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW216
12.2.5BALLYA BIO217
TABLE 199BALLYA BIO: BUSINESS OVERVIEW217
12.

Report Title: Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique Type, End User and Region (North America, APAC, MEA, Europe, Latin America) - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Artificial Intelligence in Medical Diagnostics Market By Component (Software, Services), Specialty (Radiology, Cardiology, Neurology, Obstetrics/Gynecology, Oncology), Modality (MRI, CT, X-ray, Ultrasound), End User - Global Forecast to 2029

Artificial Intelligence in Medical Diagnostics Market By Component (Software, Services), Specialty (Radiology, Cardiology, Neurology, Obstetrics/Gynecology, Oncology), Modality (MRI, CT, X-ray, Ultrasound), End User - Global Forecast to 2029

HLA Typing Market by Product (Instruments, Software), Technology (Molecular [PCR, Sequencing [Sangers, NGS]], Serology), Application (Diagnostics [Cross Match, Cancer, Infectious Disease, Transfusion], Research), End User, and Geography - Forecast to 2029

HLA Typing Market by Product (Instruments, Software), Technology (Molecular [PCR, Sequencing [Sangers, NGS]], Serology), Application (Diagnostics [Cross Match, Cancer, Infectious Disease, Transfusion], Research), End User, and Geography - Forecast to 2029

U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology), End User (Pharma Companies, Providers) - Forecast to 2029

U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology), End User (Pharma Companies, Providers) - Forecast to 2029

Medical Aesthetics Market by Product (Facial Aesthetics, Body Contouring, Cosmetic Implant, Physician Dispensed Cosmeceuticals, Skin Aesthetic, Thread Lift), End User (Hospitals, Clinics, & Medical Spas, Beauty Centers, & Home Care) - Forecast to 2029

Medical Aesthetics Market by Product (Facial Aesthetics, Body Contouring, Cosmetic Implant, Physician Dispensed Cosmeceuticals, Skin Aesthetic, Thread Lift), End User (Hospitals, Clinics, & Medical Spas, Beauty Centers, & Home Care) - Forecast to 2029

United Kingdom Hospital Market, By Ownership (Public v/s Private), By Type (General, Multispecialty, Specialty), By Type of Services (In-Patient Services v/s Out-Patient Services), By Bed Capacity (Above 500, 100-500, up to 100), By Region, Competition, Forecast & Opportunities, 2017-2027F

United Kingdom Hospital Market, By Ownership (Public v/s Private), By Type (General, Multispecialty, Specialty), By Type of Services (In-Patient Services v/s Out-Patient Services), By Bed Capacity (Above 500, 100-500, up to 100), By Region, Competition, Forecast & Opportunities, 2017-2027F

Saudi Arabia Magnetic Resonance Imaging Market, By Field Strength (High-Field MRI Systems, Low-to-Mid Field MRI Systems, Very-High-Field MRI Systems), By Type (Fixed v/s Mobile), By Architecture (Closed v/s Open), By Source (Import v/s Domestic), By Application (Brain and Neurological, Oncology, Spine and Musculoskeletal, Abdominal, Cardiac & Others), By End User (Hospitals, Imaging Centers, Ambulatory Surgical Centers & Others), By Region, Competition, Forecast & Opportunities, 2017-2027F

Saudi Arabia Magnetic Resonance Imaging Market, By Field Strength (High-Field MRI Systems, Low-to-Mid Field MRI Systems, Very-High-Field MRI Systems), By Type (Fixed v/s Mobile), By Architecture (Closed v/s Open), By Source (Import v/s Domestic), By Application (Brain and Neurological, Oncology, Spine and Musculoskeletal, Abdominal, Cardiac & Others), By End User (Hospitals, Imaging Centers, Ambulatory Surgical Centers & Others), By Region, Competition, Forecast & Opportunities, 2017-2027F